Autophagy: a critical mechanism of N
Journal
Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092
Informations de publication
Date de publication:
28 Oct 2024
28 Oct 2024
Historique:
received:
17
07
2024
accepted:
09
10
2024
revised:
06
10
2024
medline:
29
10
2024
pubmed:
29
10
2024
entrez:
29
10
2024
Statut:
epublish
Résumé
N
Identifiants
pubmed: 39468015
doi: 10.1038/s41419-024-07148-w
pii: 10.1038/s41419-024-07148-w
doi:
Substances chimiques
Adenosine
K72T3FS567
N-methyladenosine
CLE6G00625
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
783Informations de copyright
© 2024. The Author(s).
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
doi: 10.3322/caac.21492
pubmed: 30207593
Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, et al. N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161:1388–99.
pubmed: 26046440
pmcid: 4825696
doi: 10.1016/j.cell.2015.05.014
Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201–6.
pubmed: 22575960
doi: 10.1038/nature11112
Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117–20.
pubmed: 24284625
doi: 10.1038/nature12730
He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176.
pubmed: 31801551
pmcid: 6892141
doi: 10.1186/s12943-019-1109-9
Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885–7.
pubmed: 22002720
pmcid: 3218240
doi: 10.1038/nchembio.687
Liu J, Dou X, Chen C, Chen C, Liu C, Xu MM, et al. N (6)-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription. Science. 2020;367:580–6.
pubmed: 31949099
pmcid: 7213019
doi: 10.1126/science.aay6018
Zhu L, Li B, Li R, Hu L, Zhang Y, Zhang Z, et al. METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity. Cell Oncol. 2023;46:1529–41.
doi: 10.1007/s13402-023-00829-2
Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285–95.
pubmed: 29476152
pmcid: 5826585
doi: 10.1038/s41556-018-0045-z
Chang G, Shi L, Ye Y, Shi H, Zeng L, Tiwary S, et al. YTHDF3 induces the translation of m(6)A-enriched gene transcripts to promote breast cancer brain metastasis. Cancer Cell. 2020;38:857–71.e857.
pubmed: 33125861
pmcid: 7738369
doi: 10.1016/j.ccell.2020.10.004
He S, Song W, Cui S, Li J, Jiang Y, Chen X, et al. Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer. Cell Oncol. 2023;46:1731–46.
doi: 10.1007/s13402-023-00839-0
Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560–75.
pubmed: 36864290
doi: 10.1038/s41580-023-00585-z
Galluzzi L, Green DR. Autophagy-independent functions of the autophagy machinery. Cell. 2019;177:1682–99.
pubmed: 31199916
pmcid: 7173070
doi: 10.1016/j.cell.2019.05.026
Li W, He P, Huang Y, Li YF, Lu J, Li M, et al. Selective autophagy of intracellular organelles: recent research advances. Theranostics. 2021;11:222–56.
pubmed: 33391472
pmcid: 7681076
doi: 10.7150/thno.49860
Singh SS, Vats S, Chia AY, Tan TZ, Deng S, Ong MS, et al. Dual role of autophagy in hallmarks of cancer. Oncogene. 2018;37:1142–58.
pubmed: 29255248
doi: 10.1038/s41388-017-0046-6
White E. The role for autophagy in cancer. J Clin Investig. 2015;125:42–6.
pubmed: 25654549
pmcid: 4382247
doi: 10.1172/JCI73941
Lei Y, Zhang D, Yu J, Dong H, Zhang J, Yang S. Targeting autophagy in cancer stem cells as an anticancer therapy. Cancer Lett. 2017;393:33–9.
pubmed: 28216370
doi: 10.1016/j.canlet.2017.02.012
Miller DR, Thorburn A. Autophagy and organelle homeostasis in cancer. Dev Cell. 2021;56:906–18.
pubmed: 33689692
pmcid: 8026727
doi: 10.1016/j.devcel.2021.02.010
Zeng C, Huang W, Li Y, Weng H. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020;13:117.
pubmed: 32854717
pmcid: 7457244
doi: 10.1186/s13045-020-00951-w
Bokar JA, Rath-Shambaugh ME, Ludwiczak R, Narayan P, Rottman F. Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. J Biol Chem. 1994;269:17697–704.
pubmed: 8021282
doi: 10.1016/S0021-9258(17)32497-3
Bokar JA, Shambaugh ME, Polayes D, Matera AG, Rottman FM. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA. 1997;3:1233–47.
Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63:306–17.
pubmed: 27373337
pmcid: 4958592
doi: 10.1016/j.molcel.2016.05.041
Śledź P, Jinek P. Structural insights into the molecular mechanism of the m(6)A writer complex. Elife. 2016;5:e18434.
pubmed: 27627798
pmcid: 5023411
doi: 10.7554/eLife.18434
Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28:616–24.
pubmed: 29789545
pmcid: 5993786
doi: 10.1038/s41422-018-0040-8
Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature. 2016;534:575–8.
pubmed: 27281194
doi: 10.1038/nature18298
Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93–5.
pubmed: 24316715
doi: 10.1038/nchembio.1432
Wang Y, Li Y, Toth JI, Petroski MD, Zhang Z, Zhao JC. N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol. 2014;16:191–8.
pubmed: 24394384
pmcid: 4640932
doi: 10.1038/ncb2902
Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24:177–89.
Hao W, Dian M, Zhou Y, Zhong Q, Pang W, Li Z, et al. Autophagy induction promoted by m(6)A reader YTHDF3 through translation upregulation of FOXO3 mRNA. Nat Commun. 2022;13:5845.
pubmed: 36195598
pmcid: 9532426
doi: 10.1038/s41467-022-32963-0
Lin Z, Niu Y, Wan A, Chen D, Liang H, Chen X, et al. RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. EMBO J. 2020;39:e103181.
pubmed: 32368828
pmcid: 7298296
doi: 10.15252/embj.2019103181
Hua YQ, Zhang K, Sheng J, Ning ZY, Li Y, Shi WD, et al. NUCB1 suppresses growth and shows additive effects with gemcitabine in pancreatic ductal adenocarcinoma via the unfolded protein response. Front Cell Dev Biol. 2021;9:641836.
pubmed: 33855021
pmcid: 8041069
doi: 10.3389/fcell.2021.641836
Lai X, Wei J, Gu XZ, Yao XM, Zhang DS, Li F, et al. Dysregulation of LINC00470 and METTL3 promotes chemoresistance and suppresses autophagy of chronic myelocytic leukaemia cells. J Cell Mol Med. 2021;25:4248–59.
pubmed: 33749070
pmcid: 8093980
doi: 10.1111/jcmm.16478
Peng J, Zheng H, Liu F, Wu Q, Liu S. The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1. Infect Agent Cancer. 2022;17:1.
pubmed: 34980191
pmcid: 8722091
doi: 10.1186/s13027-021-00411-1
Shen W, Zhu M, Wang Q, Zhou X, Wang J, Wang T, et al. DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m(6)A modification and translation for cytoprotective autophagy in cervical cancer. RNA Biol. 2022;19:751–63.
pubmed: 35638109
pmcid: 9176263
doi: 10.1080/15476286.2022.2079889
Wang C, Meng Y, Zhao J, Ma J, Zhao Y, Gao R, et al. Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m(6)A/ATG5 axis. Int J Biol Sci. 2023;19:2289–303.
pubmed: 37151889
pmcid: 10158027
doi: 10.7150/ijbs.82081
Wu S, Weng S, Zhou W, Chen Y, Liu Z. METTL3 affects FLT3-ITD+ acute myeloid leukemia by mediating autophagy by regulating PSMA3-AS1 stability. Cell Cycle. 2023;22:1232–45.
pubmed: 37088992
pmcid: 10193868
doi: 10.1080/15384101.2023.2204770
Wang F, Zhu Y, Cai H, Liang J, Wang W, Liao Y, et al. N6-methyladenosine methyltransferase METTL14-mediated autophagy in malignant development of oral squamous cell carcinoma. Front Oncol. 2021;11:738406.
pubmed: 34900689
pmcid: 8652297
doi: 10.3389/fonc.2021.738406
Liang J, Cai H, Hou C, Song F, Jiang Y, Wang Z, et al. METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner. Clin Sci. 2023;137:1373–89.
doi: 10.1042/CS20230219
Huang Q, Mo J, Liao Z, Chen X, Zhang B. The RNA m(6)A writer WTAP in diseases: structure, roles, and mechanisms. Cell Death Dis. 2022;13:852
pubmed: 36207306
pmcid: 9546849
doi: 10.1038/s41419-022-05268-9
Huang L, Shao J, Xu X, Hong W, Yu W, Zheng S, et al. WTAP regulates autophagy in colon cancer cells by inhibiting FLNA through N6-methyladenosine. Cell Adh Migr. 2023;17:1–13.
pubmed: 36944577
pmcid: 10038045
Li G, Deng L, Huang N, Cui Z, Wu Q, Ma J, et al. m(6)A mRNA methylation regulates LKB1 to promote autophagy of hepatoblastoma cells through upregulated phosphorylation of AMPK. Genes. 2021;12:1747
pubmed: 34828353
pmcid: 8621998
doi: 10.3390/genes12111747
Li Y, Guo M, Qiu Y, Li M, Wu Y, Shen M, et al. Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma. Redox Biol. 2024;69:102971.
pubmed: 38056309
doi: 10.1016/j.redox.2023.102971
Wang J, Zheng F, Wang D, Yang Q. Regulation of ULK1 by WTAP/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer. Cell Death Dis. 2024;15:97
pubmed: 38286802
pmcid: 10824720
doi: 10.1038/s41419-024-06477-0
Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608–24.
pubmed: 31520073
doi: 10.1038/s41580-019-0168-5
Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19:88.
pubmed: 32398132
pmcid: 7216508
doi: 10.1186/s12943-020-01204-7
Dina C, Meyre D, Gallina S, Durand E, Körner A, Jacobson P, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39:724–6.
pubmed: 17496892
doi: 10.1038/ng2048
Li Z, Weng H, Su R, Weng X, Zuo Z, Li C. et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase. Cancer Cell. 2017;31:127–41.
pubmed: 28017614
doi: 10.1016/j.ccell.2016.11.017
Qu J, Yan H, Hou Y, Cao W, Liu Y, Zhang E. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. J Hematol Oncol. 2022;15:8
pubmed: 35063010
pmcid: 8780705
doi: 10.1186/s13045-022-01224-4
Zhou J, Zhang X, Hu J, Qu R, Yu Z, Xu H. et al. m(6)A demethylase ALKBH5 controls CD4(+) T cell pathogenicity and promotes autoimmunity. Sci Adv. 2021;7:eabg0470.
pubmed: 34134995
pmcid: 8208713
doi: 10.1126/sciadv.abg0470
Xu Y, Zhou J, Li L, Yang W, Zhang Z, Zhang K. et al. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability. Int J Biol Sci. 2022;18:5943–62.
pubmed: 36263177
pmcid: 9576516
doi: 10.7150/ijbs.77774
Huang J, Sun M, Tao Y, Ren J, Peng M, Jing Y, et al. Cytoplasmic expression of TP53INP2 modulated by demethylase FTO and mutant NPM1 promotes autophagy in leukemia cells. Int J Mol Sci. 2023;24:1624
pubmed: 36675134
pmcid: 9865930
doi: 10.3390/ijms24021624
Chen F, Song C, Meng F, Zhu Y, Chen X, Fang X, et al. 5’-tRF-GlyGCC promotes breast cancer metastasis by increasing fat mass and obesity-associated protein demethylase activity. Int J Biol Macromol. 2023;226:397–409.
pubmed: 36464183
doi: 10.1016/j.ijbiomac.2022.11.295
Jin S, Zhang X, Miao Y, Liang P, Zhu K, She Y, et al. m(6)A RNA modification controls autophagy through upregulating ULK1 protein abundance. Cell Res. 2018;28:955–7.
pubmed: 30046135
pmcid: 6123428
doi: 10.1038/s41422-018-0069-8
Zhang Y, Gao LX, Wang W, Zhang T, Dong FY, Ding WP. M6A demethylase fat mass and obesity-associated protein regulates cisplatin resistance of gastric cancer by modulating autophagy activation through ULK1. Cancer Sci. 2022;113:3085–96.
pubmed: 35730319
pmcid: 9459343
doi: 10.1111/cas.15469
Guo J, Wu Y, Du J, Yang L, Chen W, Gong K, et al. Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression. Oncogenesis. 2018;7:49.
pubmed: 29904125
pmcid: 6002383
doi: 10.1038/s41389-018-0054-6
Wang S, Nie J, Xu K, Liu Y, Tong W, Li A, et al. YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B. Aging. 2023;15:9590–613.
pubmed: 37724907
pmcid: 10564435
doi: 10.18632/aging.205037
Li M, Wei J, Xue C, Zhou X, Chen S, Zheng L, et al. Dissecting the roles and clinical potential of YY1 in the tumor microenvironment. Front Oncol. 2023;13:1122110.
pubmed: 37081988
pmcid: 10110844
doi: 10.3389/fonc.2023.1122110
Subbarayalu P, Yadav P, Timilsina S, Medina D, Baxi K, Hromas R. The RNA demethylase ALKBH5 maintains endoplasmic reticulum homeostasis by regulating UPR, autophagy, and mitochondrial function. Cells. 2023;12:1283
pubmed: 37174684
pmcid: 10177234
doi: 10.3390/cells12091283
Song H, Feng X, Zhang H, Luo Y, Huang J, Lin M, et al. METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy. 2019;15:1419–37.
pubmed: 30870073
pmcid: 6613905
doi: 10.1080/15548627.2019.1586246
Yu F, Zhu AC, Liu S, Gao B, Wang Y, Khudaverdyan N, et al. RBM33 is a unique m(6)A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity. Mol Cell. 2023;83:2003–2019.e2006.
pubmed: 37257451
pmcid: 10330838
doi: 10.1016/j.molcel.2023.05.010
Liu T, Wei Q, Jin J, Luo Q, Liu Y, Yang Y. et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res. 2020;48:3816–31.
pubmed: 31996915
pmcid: 7144925
doi: 10.1093/nar/gkaa048
Du H, Zhao Y, He J, Zhang Y, Xi H, Liu M, et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun. 2016;7:12626.
pubmed: 27558897
pmcid: 5007331
doi: 10.1038/ncomms12626
Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu PJ, et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 2017;27:315–28.
pubmed: 28106072
pmcid: 5339834
doi: 10.1038/cr.2017.15
Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016;61:507–19.
pubmed: 26876937
doi: 10.1016/j.molcel.2016.01.012
Kretschmer J, Rao H, Hackert P, Sloan KE, Höbartner C, Bohnsack MT. The m(6)A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5’-3’ exoribonuclease XRN1. RNA. 2018;24:1339–50.
pubmed: 29970596
pmcid: 6140455
doi: 10.1261/rna.064238.117
Fang Z, Mei W, Qu C, Lu J, Shang L, Cao F, et al. Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol. 2022;11:45.
pubmed: 35945641
pmcid: 9361621
doi: 10.1186/s40164-022-00298-7
Shi R, Ying S, Li Y, Zhu L, Wang X, Jin H. Linking the YTH domain to cancer: the importance of YTH family proteins in epigenetics. Cell Death Dis. 2021;12:346.
pubmed: 33795663
pmcid: 8016981
doi: 10.1038/s41419-021-03625-8
Shen M, Li Y, Wang Y, Shao J, Zhang F, Yin G, et al. N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells. Redox Biol. 2021;47:102151.
pubmed: 34607160
pmcid: 8495178
doi: 10.1016/j.redox.2021.102151
Hao W, Dian M, Wang J, Sun Y, Xiao D. Epitranscriptomic turbo for autophagy boost: m(6)A reader YTHDF3. Autophagy. 2023;19:1882–4.
pubmed: 36374269
doi: 10.1080/15548627.2022.2146890
Liang D, Lin WJ, Ren M, Qiu J, Yang C, Wang X, et al. m6A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin. Autophagy. 2022;18:1318–37.
pubmed: 34657574
doi: 10.1080/15548627.2021.1974175
Zhu TY, Hong LL, Ling ZQ. Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. Biomark Res. 2023;11:62.
pubmed: 37280679
pmcid: 10245617
doi: 10.1186/s40364-023-00499-0
Gao Z, Li C, Sun H, Bian Y, Cui Z, Wang N, et al. N6-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors. Cell Death Differ. 2023;30:544–59.
pubmed: 36528756
doi: 10.1038/s41418-022-01107-8
Han L, Lei G, Chen Z, Zhang Y, Huang C, Chen W. IGF2BP2 regulates MALAT1 by serving as an N6-methyladenosine reader to promote NSCLC proliferation. Front Mol Biosci. 2021;8:780089
pubmed: 35111811
doi: 10.3389/fmolb.2021.780089
Yang L, Yan B, Qu L, Ren J, Li Q, Wang J, et al. IGF2BP3 regulates TMA7-mediated autophagy and cisplatin resistance in laryngeal cancer via m6A RNA methylation. Int J Biol Sci. 2023;19:1382–1400.
pubmed: 37056932
pmcid: 10086756
doi: 10.7150/ijbs.80921
Zheng R, Yu Y, Lv L, Zhang Y, Deng H, Li J. et al. m6A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer. Exp. Cell Res. 2023;424:113487.
pubmed: 36693492
doi: 10.1016/j.yexcr.2023.113487
Yang C, Zhang Y, Du W, Cheng H, Li C. Eukaryotic translation initiation factor 3 subunit G promotes human colorectal cancer. Am J Transl Res. 2019;11:612–23.
pubmed: 30899366
pmcid: 6413245
Shintani T, Higashisaka K, Maeda M, Hamada M, Tsuji R, Kurihara K, et al. Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer. Oncotarget. 2018;9:37520–33.
pubmed: 30680067
pmcid: 6331022
doi: 10.18632/oncotarget.26494
Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19:12.
pubmed: 31969156
pmcid: 6975070
doi: 10.1186/s12943-020-1138-4
Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8:741–52.
pubmed: 17717517
doi: 10.1038/nrm2239
Xu Z, Han X, Ou D, Liu T, Li Z, Jiang G, et al. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy. Appl Microbiol Biotechnol. 2020;104:575–87.
pubmed: 31832711
doi: 10.1007/s00253-019-10257-8
Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21:183–203.
pubmed: 31937935
pmcid: 7102936
doi: 10.1038/s41580-019-0199-y
Du A, Li S, Zhou Y, Disoma C, Liao Y, Zhang Y, et al. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer. 2022;21:109.
pubmed: 35524319
pmcid: 9074191
doi: 10.1186/s12943-022-01575-z
Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960–76.
pubmed: 28283069
pmcid: 5394987
doi: 10.1016/j.cell.2017.02.004
Kao CH, Su TY, Huang WS, Lu XY, Jane WN, Huang CY, et al. TFEB- and TFE3-dependent autophagy activation supports cancer proliferation in the absence of centrosomes. Autophagy. 2022;18:2830–50.
pubmed: 35316161
pmcid: 9673955
doi: 10.1080/15548627.2022.2051880
Romanov J, Walczak M, Ibiricu I, Schüchner S, Ogris E, Kraft C, et al. Mechanism and functions of membrane binding by the Atg5-Atg12/Atg16 complex during autophagosome formation. EMBO J. 2012;31:4304–17.
pubmed: 23064152
pmcid: 3501226
doi: 10.1038/emboj.2012.278
Matsushita M, Suzuki NN, Obara K, Fujioka Y, Ohsumi Y, Inagaki F. Structure of Atg5.Atg16, a complex essential for autophagy. J Biol Chem. 2007;282:6763–72.
pubmed: 17192262
doi: 10.1074/jbc.M609876200
Walczak M, Martens S. Dissecting the role of the Atg12-Atg5-Atg16 complex during autophagosome formation. Autophagy. 2013;9:424–5.
pubmed: 23321721
pmcid: 3590266
doi: 10.4161/auto.22931
Zheng W, Xie W, Yin D, Luo R, Liu M, Guo F. ATG5 and ATG7 induced autophagy interplays with UPR via PERK signaling. Cell Commun Signal. 2019;17:42.
pubmed: 31060556
pmcid: 6503447
doi: 10.1186/s12964-019-0353-3
Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol. 2010;22:124–31.
pubmed: 20034776
doi: 10.1016/j.ceb.2009.11.014
Pei H, Dai Y, Yu Y, Tang J, Cao Z, Zhang Y, et al. The Tumorigenic effect of lncRNA AFAP1-AS1 is mediated by translated peptide ATMLP under the control of m(6) a methylation. Adv Sci. 2023;10:e2300314.
doi: 10.1002/advs.202300314
Kimura S, Noda T, Yoshimori T. Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. Cell Struct Funct. 2008;33:109–22.
pubmed: 18388399
doi: 10.1247/csf.08005
Wijdeven RH, Janssen H, Nahidiazar L, Janssen L, Jalink K, Berlin I, et al. Cholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway. Nat Commun. 2016;7:11808.
pubmed: 27283760
pmcid: 4906411
doi: 10.1038/ncomms11808
Tang J, Zheng F, Liu X, Li Y, Guo Z, Lin X. et al. Cobalt induces neurodegeneration through FTO-triggered autophagy impairment by targeting TSC1 in an m6A-YTHDF2-dependent manner. J Hazard Mater. 2023;453:131354.
pubmed: 37054644
doi: 10.1016/j.jhazmat.2023.131354
Han S, Zhu L, Zhu Y, Meng Y, Li J, Song P, et al. Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition. Theranostics. 2021;11:8464–79.
pubmed: 34373753
pmcid: 8343999
doi: 10.7150/thno.60028
Du F, Sun L, Chu Y, Li T, Lei C, Wang X, et al. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways. Cancer Commun. 2018;38:45.
doi: 10.1186/s40880-018-0315-y
Zhang Y, Liu X, Wang Y, Lai S, Wang Z, Yang Y, et al. The m(6)A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway. Mol Cancer. 2022;21:174.
pubmed: 36056355
pmcid: 9438157
doi: 10.1186/s12943-022-01647-0
Fu Y, Liu L, Wu H, Zheng Y, Zhan H, Li L. LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis. Mol Cell Biochem. 2024;479:553–66.
pubmed: 37120495
doi: 10.1007/s11010-023-04748-6
Zhang C, Wang Y, Zhen Z, Li J, Su J, Wu C. mTORC1 mediates biphasic mechano-response to orchestrate adhesion-dependent cell growth and anoikis resistance. Adv Sci. 2023;11:e2307206.
doi: 10.1002/advs.202307206
Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, et al. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther. 2021;6:404.
pubmed: 34803167
pmcid: 8606574
doi: 10.1038/s41392-021-00817-8
Mah LY, Ryan KM. Autophagy and cancer. Cold Spring Harb Perspect Biol. 2012;4:a008821.
pubmed: 22166310
pmcid: 3249624
doi: 10.1101/cshperspect.a008821
Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg Chem. 2019;88:102925.
pubmed: 31003078
doi: 10.1016/j.bioorg.2019.102925
Chen H, Xiang Y, Yin Y, Peng J, Peng D, Li D, et al. The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma. Transl Androl Urol. 2021;10:1711–22.
pubmed: 33968659
pmcid: 8100844
doi: 10.21037/tau-20-1411
Zhu L, Zhu Y, Han S, Chen M, Song P, Dai D, et al. Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer. Cell Death Dis. 2019;10:383.
pubmed: 31097692
pmcid: 6522595
doi: 10.1038/s41419-019-1585-2
Sun Y, Shen W, Hu S, Lyu Q, Wang Q, Wei T, et al. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. J Exp Clin Cancer Res. 2023;42:65.
pubmed: 36932427
pmcid: 10022264
doi: 10.1186/s13046-023-02638-9
Yu H, Zhuang J, Zhou Z, Song Q, Lv J, Yang X, et al. METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway. Int J Biol Sci. 2024;20:1471–91.
pubmed: 38385084
pmcid: 10878153
doi: 10.7150/ijbs.86719
Feng S, Qiu G, Yang L, Feng L, Fan X, Ren F. et al. Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation. Biosci Rep. 2021;41:BSR20200842.
pubmed: 33393595
pmcid: 7843496
doi: 10.1042/BSR20200842
Yang J, Li L, Cheng J, Lu J, Zhang S, Wang S, et al. The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia. J Cancer Res Clin Oncol. 2023;149:11457–69.
pubmed: 37391640
doi: 10.1007/s00432-023-05029-x
Nie G, Tang B, Lv M, Li D, Li T, Ou R. et al. HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition. Cell Biol Int. 2023;47:1327–43.
pubmed: 37191290
doi: 10.1002/cbin.12020
Wang Y, Lu JH, Wu QN, Jin Y, Wang DS, Chen YX, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer. 2019;18:174.
pubmed: 31791342
pmcid: 6886219
doi: 10.1186/s12943-019-1105-0
Yang Z, Yang S, Cui YH, Wei J, Shah P, Park G. et al. METTL14 facilitates global genome repair and suppresses skin tumorigenesis. Proc Natl Acad Sci USA. 2021;118:e2025948118.
pubmed: 34452996
pmcid: 8536359
doi: 10.1073/pnas.2025948118
Yang S, Wei J, Cui Y, Shah P, Deng Y, Aplin A, et al. 820 m6A mRNA demethylase FTO regulates tumorigenicity and response to anti-PD-1 immunotherapy in melanoma. J Investig Dermatol. 2019;139:S141.
doi: 10.1016/j.jid.2019.03.896
Cui Y, Yang S, Wei J, Shea CR, Zhong W, Wang F, et al. 084 mRNA methylation in skin tumorigenesis and therapeutic resistance. J Investig Dermatol. 2022;142:S14.
doi: 10.1016/j.jid.2022.05.019
Wei W, Zhang ZY, Shi B, Cai Y, Zhang HS, Sun CL, et al. METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression. J Exp Clin Cancer Res. 2023;42:151.
pubmed: 37340443
pmcid: 10280857
doi: 10.1186/s13046-023-02732-y
Li Q, Ni Y, Zhang L, Jiang R, Xu J, Yang H, et al. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Signal Transduct Target Ther. 2021;6:76.
Yu X, Liu J, Xie R, Chang M, Xu B, Zhu Y, et al. Construction of a prognostic model for lung squamous cell carcinoma based on seven N6-methylandenosine-related autophagy genes. Math Biosci Eng. 2021;18:6709–23.
pubmed: 34517553
doi: 10.3934/mbe.2021333
Chen F, Gong E, Ma J, Lin J, Wu C, Chen S, et al. Prognostic score model based on six m6A-related autophagy genes for predicting survival in esophageal squamous cell carcinoma. J Clin Lab Anal. 2022;36:e24507.
Zhang Y, Xu L, Ren Z, Liu X, Song J, Zhang P, et al. LINC01615 maintains cell survival in adaptation to nutrient starvation through the pentose phosphate pathway and modulates chemosensitivity in colorectal cancer. Cell Mol Life Sci. 2023;80:20.
doi: 10.1007/s00018-022-04675-7
Liu S, Li Q, Li G, Zhang Q, Zhuo L, Han X, et al. The mechanism of m(6)A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene. Cell Death Dis. 2020;11:969.
pubmed: 33177491
pmcid: 7658972
doi: 10.1038/s41419-020-03148-8